Therapies13 August 2026· 11 min read
NICE Moves Type 2 Diabetes First-Line Therapy to SGLT2
NICE NG28 now recommends SGLT2 inhibitors as first-line therapy alongside metformin for most adults with type 2 diabetes, prioritising cardiorenal protection from diagnosis.
By Dr. Eleanor Vance, Regulatory Affairs Editor